Hypertension guidelines: Criteria that might make them more clinically useful

American Journal of Hypertension

Volumn 15, Issue 10 I, 2002, Pages 917-923

  Alderman, Michael H ^a   Furberg, Curt D ^b   Kostis, John B ^c   Laragh, John H ^d   Psaty, Bruce M ^e   Ruilope, Luis M ^f   Volpe, Massimo ^g   Jackson, Rodney ^h  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Hypertension; Treatment guidelines

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; COMORBIDITY; DISEASE CONTROL; DRUG INDICATION; DRUG USE; FEMALE; HUMAN; HYPERTENSION; LIFESTYLE; MALE; PATIENT ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR;

HUMANS; HYPERTENSION; PRACTICE GUIDELINES; RISK FACTORS;

EID: 0036794827     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(02)03001-7     Document Type: Review

References (29)

1. Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-2446.
2. Guidelines Subcommittee, World Health Organization-International Society of Hypertension: Guidelines for the management of hypertension. J Hypertens 1999;17:151-183.
3. Ramsay L, Williams B, Johnston G, MacGregor G, Poton L, Poter J, et al: Guideline for management of hypertension: Report of the third working party of the British Hypertension Society. J Hum Hypertens 1999;13:569-592.
4. Berlowitz DR, Ash AS, Hickey EC, Freidman RH, Glickman M, Kaden B, Miskowitz MA: Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998;339:1957-1963.
5. Oliveria SA, Lapuerta P, McCarthy BD, L'Italien GJ, Berlowitz DR, Asch SM: Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med 2002;162:413-420.
6. Hyman D, Pavlik V: Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 2000;345:479-486.
7. Furberg CD, Psaty BM, Pahor M, Alderman MH: Clinical implications of Recent Findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and other studies of hypertension. Ann Intern Med 2001;135:1074-1078.
8. Kopp C, Tarr A, Nabarro D: All commercial enterprises should be excluded from the development process and World Health Organization's response. BMJ 2000;321:958-959.
9. Choudhry NK, Stelfox HT, Detsky AS: Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 2002;287:612-617.
10. Ramsay LE, Williams B, Johnston GD, MacGregor GA, Poston L, Potter JF, Poulter NR, Russell G: British Hypertension Society guidelines for hypertension management 1999: Summary. BMJ 1999;319:630-635.
11. U.S. Preventive Services Task Force: Guide to Clinical Preventive Services, 2nd ed. Alexandria, Virginia, International Medical Publishing, 1996.
12. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE III, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Eagle KA, Faxon DP, Fuster V, Gardner TJ, Greposatos G, Russell RO, Smith C Jr: ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: Executive summary and recommendations. Circulation 2000;102:1193-1209.
13. Grundy SM, D'Agostino RB, Mosca L, Burke GL, Wilson PW, Rader DJ, Cleeman JI, Rochella EJ, Cutler JA, Freidman LM: Cardiovascular risk assessment based on US cohort studies: Findings from a National Heart, Lung and Blood Institute workshop. Circulation 2001;104:491-496.
14. Friedmann P, Brett A, Mayo-Smith M: Differences in generalists' and cardiologists perceptions of cardiovascular risk and the outcomes of preventive therapy in cardiovascular disease. Ann Intern Med 1996;124:414-421.
15. Jackson R: Updated New Zealand cardiovascular disease risk-benefit prediction guide. BMJ 2000;320:709-710.
16. Wood D, McInnes G, Rees A, Wray R: Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1998;80:S1-S29.
17. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K: Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis 1998;140:199-270.
18. NZ electronic charts www.nzgg.org.nz/library/gl complete/blood-pressure/
19. British electronic charts www.hyp.ac.uk/bhs/
20. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB: Prediction of coronary heart disease using risk factors categories. Circulation 1998;97:1837-1847.
21. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beece PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM: Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPA/TexCAPS. JAMA 1998;279:1615-1622.
22. Psaty BM, Smith NS, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, Lemaitre RN, Wagner EH, Furberg CD: Health outcomes associated with anti-hypertensive therapies used as first-line agents: A systematic review and meta-analysis. JAMA 1997;277:739-745.
23. Hayden M, Pignone M, Phillips C, Mulrow C: Aspirin for the primary prevention of cardiovascular events: A summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002;136:161-172.
24. Pignone M, Phillips C, Mulrow C: Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials. BMJ 2000;321:983-986.
25. Montgomery AA, Fahey T, Peters TJ, MacIntosh C, Sharp D: Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: Randomized controlled trial. BMJ 2000;320:686-690.
26. Montgomery AA, Harding J, Fahey T: Shared decision making in hypertension: The impact of patient preferences on treatment choice. Family Pract 2001;18:309.
27. Cochrane Library. http://www.update-software
28. National Guideline Clearinghouse Agency for Healthcare Research and Quality. http://www.AHRQ.gov/index.asp
29. Sennett G: Implementing the HEDIS hypertension performance measure. Managed Care 2000;9(Suppl 4):2-21.